Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
150 JPY | +7.14% | +13.64% | -9.09% |
Feb. 26 | Japanese Shares Hit Fresh 52-Week Peak Ahead of Inflation Data | MT |
Feb. 26 | Healios Proposes Reduction of Capital Stock, Reserves, Surplus Appropriation | MT |
Sales 2023 | 121M 799K | Sales 2024 * | 910M 6.01M | Capitalization | 13.52B 89.27M |
---|---|---|---|---|---|
Net income 2023 | -3.82B -25.24M | Net income 2024 * | -2.69B -17.78M | EV / Sales 2023 | 82.5 x |
Net Debt 2023 | 2.31B 15.28M | Net cash position 2024 * | 822M 5.43M | EV / Sales 2024 * | 14 x |
P/E ratio 2023 |
-2.93
x | P/E ratio 2024 * |
-4.52
x | Employees | 71 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 62.6% |
1 day | +7.14% | ||
1 week | +13.64% | ||
Current month | +10.29% | ||
1 month | +13.64% | ||
3 months | -14.77% | ||
6 months | -35.62% | ||
Current year | -9.09% |
Managers | Title | Age | Since |
---|---|---|---|
Hardy Kagimoto
CEO | Chief Executive Officer | 47 | 11-02-23 |
Richard Kincaid
DFI | Director of Finance/CFO | 47 | 18-02-28 |
Masanori Sawada
CTO | Chief Tech/Sci/R&D Officer | 42 | 12-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 62 | 12-12-31 | |
Director/Board Member | 71 | 18-02-28 | |
Cam Gallagher
BRD | Director/Board Member | 54 | 22-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 150 | +7.14% | 1 258 300 |
24-03-27 | 140 | -2.10% | 1,174,900 |
24-03-26 | 143 | -2.72% | 1,088,900 |
24-03-25 | 147 | -2.65% | 1,065,800 |
24-03-22 | 151 | +3.42% | 2,286,800 |
Delayed Quote Japan Exchange, March 28, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.09% | 83.36M | |
+3.16% | 108B | |
+9.86% | 104B | |
+6.58% | 23.66B | |
-12.36% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-12.91% | 16.19B | |
+4.89% | 13.72B | |
+34.81% | 12.22B |